Comet-1
Meta informatie
Publicatiedatum: 13-10-2003
Versie: 0.9
Ziektebeeld:  Urogenitaal > Prostaatcarcinoom
Fase:  Palliatief
Type:  Studie (pro)
Status:  Gesloten
Artikel code: D137
Auteur: admin

Comet-1

Acties

A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) vs. Prednisone in Metastatic Castrationresistant Prostate Cancer Patients who have Received Prior Docetaxel and Prior Abiraterone or MDV3100.